发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Intravenous acetaminophen/ibuprofen (Combogesic IV). 静脉注射对乙酰氨基酚/布洛芬（Combogesic IV）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701c
{"title":"Intravenous acetaminophen/ibuprofen (Combogesic IV).","authors":"","doi":"10.58347/tml.2024.1701c","DOIUrl":"https://doi.org/10.58347/tml.2024.1701c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison Table: Some Topical Drugs for Rosacea. 对照表：一些治疗红斑痤疮的外用药物
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701f
{"title":"Comparison Table: Some Topical Drugs for Rosacea.","authors":"","doi":"10.58347/tml.2024.1701f","DOIUrl":"https://doi.org/10.58347/tml.2024.1701f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifileucel (Amtagvi): A cellular therapy for melanoma. Lifileucel（Amtagvi）：一种治疗黑色素瘤的细胞疗法。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701h
{"title":"Lifileucel (Amtagvi): A cellular therapy for melanoma.","authors":"","doi":"10.58347/tml.2024.1701h","DOIUrl":"10.58347/tml.2024.1701h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new indication for semaglutide (Wegovy). semaglutide（Wegovy）的新适应症。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701b
{"title":"A new indication for semaglutide (Wegovy).","authors":"","doi":"10.58347/tml.2024.1701b","DOIUrl":"https://doi.org/10.58347/tml.2024.1701b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iDose TR - a travoprost implant for glaucoma. iDose TR - 一种用于青光眼的曲伏前列素植入物。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701d
{"title":"iDose TR - a travoprost implant for glaucoma.","authors":"","doi":"10.58347/tml.2024.1701d","DOIUrl":"https://doi.org/10.58347/tml.2024.1701d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belzutifan (Welireg) for advanced renal cell carcinoma. 贝珠替凡（Welireg）治疗晚期肾细胞癌。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701g
{"title":"Belzutifan (Welireg) for advanced renal cell carcinoma.","authors":"","doi":"10.58347/tml.2024.1701g","DOIUrl":"https://doi.org/10.58347/tml.2024.1701g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic prophylaxis for dental procedures. 牙科手术的抗生素预防。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701e
{"title":"Antibiotic prophylaxis for dental procedures.","authors":"","doi":"10.58347/tml.2024.1701e","DOIUrl":"10.58347/tml.2024.1701e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis. Resmetirom（Rezdiffra）治疗代谢功能障碍相关性脂肪性肝炎。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701a
{"title":"Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis.","authors":"","doi":"10.58347/tml.2024.1701a","DOIUrl":"10.58347/tml.2024.1701a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cabtreo: A three-drug gel for acne. Cabtreo：治疗痤疮的三药凝胶
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700b
{"title":"Cabtreo: A three-drug gel for acne.","authors":"","doi":"10.58347/tml.2024.1700b","DOIUrl":"https://doi.org/10.58347/tml.2024.1700b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roflumilast foam (Zoryve) for seborrheic dermatitis. 治疗脂溢性皮炎的罗氟司特泡沫剂（Zoryve）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700a
{"title":"Roflumilast foam (Zoryve) for seborrheic dermatitis.","authors":"","doi":"10.58347/tml.2024.1700a","DOIUrl":"https://doi.org/10.58347/tml.2024.1700a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信